# Rockwell Medical Repeats $400 Million to $450 Million Revenue Projection

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/55834
Published: 2026-11-12T19:55:54.000Z
Updated: 2026-11-12T19:55:54.000Z
Section: Business

> The deal has a $125 million base price and is expected to close in mid-2027, subject to approvals and other conditions.

Rockwell Medical reiterated a projection that its combined business with Vantive’s hemodialysis business could generate $400 million to $450 million in annual revenue, with the acquisition expected to close in mid-2027.

The company repeated the projection in its Nov. 12 third-quarter results release. It depends on business performance, foreign exchange rates, market conditions and successful integration.

Rockwell agreed Nov. 3 to acquire Vantive’s hemodialysis business, including equipment, water treatment systems and technical services. The deal’s [previously disclosed terms](<https://www.tokenpost.com/news/business/47821>) set a $125 million base price, subject to customary adjustments. The transaction is expected to close in mid-2027, pending regulatory approvals and other closing conditions.

Rockwell also pulled its 2026 outlook for net sales, gross margin, adjusted EBITDA and operating cash flow, pointing to expected transaction and financing costs.



## Links in this article

- [previously disclosed terms](https://www.tokenpost.com/news/business/47821)
